Advertisement
Research ArticleMinireviews

Combretastatins: More Than Just Vascular Targeting Agents?

Lisa M. Greene, Mary J. Meegan and Daniela M. Zisterer
Journal of Pharmacology and Experimental Therapeutics November 2015, 355 (2) 212-227; DOI: https://doi.org/10.1124/jpet.115.226225

Article Information

vol. 355 no. 2 212-227
DOI 
https://doi.org/10.1124/jpet.115.226225
PubMed 
26354991
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received May 26, 2015
  • Accepted August 25, 2015
  • Published online October 8, 2015.

Article Versions

Copyright & Usage 
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Lisa M. Greene,
  2. Mary J. Meegan, and
  3. Daniela M. Zisterer
  1. School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute (L.M.G., D.M.Z.), and School of Pharmacy and Pharmaceutical Sciences, Centre for Synthesis and Chemical Biology (M.J.M.), Trinity College Dublin, Dublin, Ireland
  1. Address correspondence to:
    Dr. Lisa M. Greene, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland. E-mail: greeneli{at}tcd.ie
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2015 to November 2023

AbstractFullPdf
Sep 2015110066
Oct 2015452838
Nov 2015951417
Dec 201595512
Jan 2016911528
Feb 2016501520
Mar 2016692028
Apr 201659913
May 201650612
Jun 2016421112
Jul 201645619
Aug 201677618
Sep 2016661118
Oct 2016252726
Nov 201663521
Dec 201612935
Jan 201703239
Feb 201704655
Mar 201736158
Apr 201732333
May 201762242
Jun 201731822
Jul 201781423
Aug 201792124
Sep 201761915
Oct 201773019
Nov 201772620
Dec 20176249
Jan 201834314
Feb 201893913
Mar 201874522
Apr 201844537
May 201853625
Jun 2018131916
Jul 201863019
Aug 201841910
Sep 201811214
Oct 201822215
Nov 201831514
Dec 20182209
Jan 201972912
Feb 201943023
Mar 201942828
Apr 201911717
May 201933919
Jun 201932216
Jul 201931718
Aug 2019102815
Sep 201911716
Oct 201933653
Nov 201903426
Dec 201962410
Jan 20201128
Feb 202022915
Mar 202013121
Apr 202001927
May 202001917
Jun 202021515
Jul 20201174
Aug 202022517
Sep 20202166
Oct 202052112
Nov 2020579
Dec 202041614
Jan 202141619
Feb 202121412
Mar 2021102918
Apr 20212138
May 202117319
Jun 20214146
Jul 202121413
Aug 202101710
Sep 202162715
Oct 20213064
Nov 20213731
Dec 20213522
Jan 20222328
Feb 20222513
Mar 20224811
Apr 20221826
May 20222120
Jun 20222342
Jul 20223040
Aug 20223136
Sep 20223814
Oct 20223721
Nov 20222632
Dec 20223435
Jan 20232532
Feb 20232742
Mar 20232222
Apr 20231123
May 2023824
Jun 20232321
Jul 20232110
Aug 20232310
Sep 20231420
Oct 20232204
Nov 20231136

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleMinireviews

Combretastatins: More Than Just Vascular Targeting Agents?

Lisa M. Greene, Mary J. Meegan and Daniela M. Zisterer
Journal of Pharmacology and Experimental Therapeutics November 1, 2015, 355 (2) 212-227; DOI: https://doi.org/10.1124/jpet.115.226225
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement